Drug Profile
Research programme: anti-viral therapeutics - National Institute of Child Health and Human Development/Viriom
Latest Information Update: 28 Feb 2021
Price :
$50
*
At a glance
- Originator National Institute of Child Health and Human Development; Viriom
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Viral infections
Most Recent Events
- 28 Feb 2021 No recent reports of development identified for research development in Viral-infections in USA
- 06 Jan 2017 Early research in Viral infections in USA
- 06 Jan 2017 National Institute of Child Health and Human Development and Viriom agree to co-develop anti-viral therapeutics in US for Viral infections